Top

Published in:

01-08-2016 | SSAT Controversy in GI Surgery Debate

Postoperative Medical Management of Crohn’s Disease: Prevention and Surveillance Strategies

Authors: Miguel Regueiro, Scott A. Strong, Linda Ferrari, Alessandro Fichera

Published in: Journal of Gastrointestinal Surgery | Issue 8/2016

Excerpt

Crohn’s disease is a chronic, unremitting inflammatory disorder that potentially affects the entire gastrointestinal tract and its recurrent nature has been long recognized. Investigators have accordingly strived to help patients avoid recurrence through efforts to elucidate the disease’s pathogenesis, measure the magnitude of the problem, understand associated risk factors, detect inflammation before it clinically manifests itself, and trial preventive medical therapies. Despite these initiatives, patients undergoing operative management of their disease remain at risk for disease recurrence. …

Fiocchi, C., Inflammatory bowel disease pathogenesis: where are we? J Gastroenterol Hepatol, 2015. 30 Suppl 1: p. 12-8.

D’Haens, G.R., et al., Early lesions of recurrent Crohn’s disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology, 1998. 114(2): p. 262-7.

Rutgeerts, P., et al., Effect of faecal stream diversion on recurrence of Crohn’s disease in the neoterminal ileum. Lancet, 1991. 338(8770): p. 771-4.

Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science 2012; 336: 1268–73.

Rutgeerts, P., et al., Predictability of the postoperative course of Crohn’s disease. Gastroenterology, 1990. 99(4): p. 956-63.

Buisson, A., et al., Review article: the natural history of postoperative Crohn’s disease recurrence. Aliment Pharmacol Ther, 2012. 35(6): p. 625-33.

Frolkis, A.D., et al., Cumulative incidence of second intestinal resection in Crohn’s disease: a systematic review and meta-analysis of population-based studies. Am J Gastroenterol, 2014. 109(11): p. 1739-48.

Ahmed, T., et al., Pathogenesis of postoperative recurrence in Crohn’s disease. Gut, 2011. 60(4): p. 553-62.

Connelly, T.M. and E. Messaris, Predictors of recurrence of Crohn’s disease after ileocolectomy: a review. World J Gastroenterol, 2014. 20(39): p. 14393-406.

10.

Wright, E.K., et al., Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn’s disease after surgery. Gastroenterology, 2015. 148(5): p. 938-947 e1

11.

Yamamoto, T., et al., Faecal calprotectin and lactoferrin as markers for monitoring disease activity and predicting clinical recurrence in patients with Crohn’s disease after ileocolonic resection: A prospective pilot study. United European Gastroenterol J, 2013. 1(5): p. 368-74.

12.

Regueiro M, Schraut E, Baidoo L, Kip KE, Sepulved AR, Pesci M, Harrison J, Plevy SE. Infliximab for prevents Crohn’s disease recurrence after ileal resection. Gastroenterology 2009;136: 441-450.e1.

13.

Yoshida K, Fukunaga K, Ikeuchi H, Kamikozuru K, Hida N, Ohda Y, Yokoyama Y, Iimuro M, Takeda N, Kato K, Kikuyama R, Nagase K, Hori K, Nakamura S, Miwa H, Matsumoto T. Scheduled infliximab monotherapy to prevent infliximab monotherapy to prevent recurrence of Crohn’s disease following ileocolonic or ileal resection: a 3-year prospective randomized open trial. Inflamm Bowel Dis 2012;18:1617-1623.

14.

Sorrentino, D., et al., Early diagnosis and treatment of postoperative endoscopic recurrence of Crohn’s disease: partial benefit by infliximab--a pilot study. Dig Dis Sci, 2012. 57(5): p. 1341-8.

15.

Papamichael, K., et al., Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn’s disease: a prospective, two-year, single center, pilot study. J Crohns Colitis, 2012. 6(9): p. 924-31.

16.

PREVENT trial ClinicalTrials.gov NCT01190839. [https://clinicaltrials.gov/ct2/show/results/NCT01190839]

17.

De Cruz P, Kamm MA, Hamilton AL, Ritchie KJ, Krejany EO, Gorelik A, et al. Crohn’s disease management after intestinal resection: a randomised trial. Lancet. 2015;11;385(9976):1406-17.

18.

Yamamoto, T., S. Umegae, and K. Matsumoto, Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn’s disease: a prospective pilot study. Inflamm Bowel Dis, 2009. 15(10): p. 1460-6.

19.

Doherty, G.A., et al., Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn’s disease. Inflamm Bowel Dis, 2012. 18(9): p. 1608-16.

20.

Regueiro M. Management and prevention of postoperative Crohn’s disease. Inflamm Bowel Dis. 15(10), p. 1583-90(2009).

21.

Ng SC and Kamm MA. Management of postoperative Crohn’s disease. Am J Gastroenterol. 103(4), p. 1029-35(2008).

Title: Postoperative Medical Management of Crohn’s Disease: Prevention and Surveillance Strategies
Authors: Miguel Regueiro
Scott A. Strong
Linda Ferrari
Alessandro Fichera
Publication date: 01-08-2016
Publisher: Springer US
Published in: Journal of Gastrointestinal Surgery / Issue 8/2016
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-016-3172-5

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Postoperative Medical Management of Crohn’s Disease: Prevention and Surveillance Strategies

Excerpt

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 8/2016

Response on: C-reactive Protein as a Predictor for Complications Following Esophagectomy

Choledochal Cyst Disease in a Western Center: A 30-Year Experience

Giant Malignant Insulinoma

Should We Use the Model for End-Stage Liver Disease (MELD) to Predict Mortality After Colorectal Surgery?

Use of Prophylactic Antibiotics to Prevent Abscess Formation Following Hepatic Ablation in Patients with Prior Enterobiliary Manipulation

Extra-Adrenal Retroperitoneal Paraganglioma with Extensive Duodenal Invasion and Inferior Vena Cava Tumor Thrombus